Understand the molecule, the evidence and what remains unknown.
Compound guides. Original sources. A clearer perspective.
Three receptor targets make retatrutide a distinctive metabolic research molecule. Clinical evidence now includes phase 3 studies, with important differences between populations and outcomes.
Read the overviewTirzepatide connects GIP and GLP-1 receptor biology with a substantial clinical research programme. Understanding the molecule starts with separating its mechanism, study results and the identity of a finished medicine.
Read the overview
